Green Fresh Biotechnology Balance Sheet Health
Financial Health criteria checks 2/6
Green Fresh Biotechnology has a total shareholder equity of CN¥830.0M and total debt of CN¥547.7M, which brings its debt-to-equity ratio to 66%. Its total assets and total liabilities are CN¥1.6B and CN¥725.5M respectively. Green Fresh Biotechnology's EBIT is CN¥57.6M making its interest coverage ratio 2.2. It has cash and short-term investments of CN¥81.3M.
Key information
65.99%
Debt to equity ratio
CN¥547.71m
Debt
| Interest coverage ratio | 2.2x |
| Cash | CN¥81.32m |
| Equity | CN¥829.98m |
| Total liabilities | CN¥725.53m |
| Total assets | CN¥1.56b |
Recent financial health updates
Green Future Food Hydrocolloid Marine Science (HKG:1084) Has A Pretty Healthy Balance Sheet
Apr 29
We Think Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Taking Some Risk With Its Debt
Dec 28
Recent updates
Green Future Food Hydrocolloid Marine Science Company Limited's (HKG:1084) CEO Might Not Expect Shareholders To Be So Generous This Year
May 30Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084) Might Not Be As Mispriced As It Looks
Sep 05Should Shareholders Worry About Green Future Food Hydrocolloid Marine Science Company Limited's (HKG:1084) CEO Compensation Package?
May 31Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Aiming To Keep Up Its Impressive Returns
Apr 19Estimating The Fair Value Of Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084)
Feb 19Investors Shouldn't Overlook The Favourable Returns On Capital At Green Future Food Hydrocolloid Marine Science (HKG:1084)
Dec 18Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Increasing Its Dividend To HK$0.03
Jun 04Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Increasing Its Dividend To HK$0.03
Apr 03Should You Be Adding Green Future Food Hydrocolloid Marine Science (HKG:1084) To Your Watchlist Today?
Mar 10Green Future Food Hydrocolloid Marine Science (HKG:1084) Has Announced That It Will Be Increasing Its Dividend To HK$0.02
Sep 02Be Wary Of Green Future Food Hydrocolloid Marine Science (HKG:1084) And Its Returns On Capital
Sep 01Here's What's Concerning About Green Future Food Hydrocolloid Marine Science's (HKG:1084) Returns On Capital
May 25Green Future Food Hydrocolloid Marine Science (HKG:1084) Has A Pretty Healthy Balance Sheet
Apr 29Green Future Food Hydrocolloid Marine Science (HKG:1084) Has Re-Affirmed Its Dividend Of HK$0.025
Apr 04Green Future Food Hydrocolloid Marine Science (HKG:1084) Will Pay A Smaller Dividend Than Last Year
Sep 02Green Future Food Hydrocolloid Marine Science (HKG:1084) Could Be Struggling To Allocate Capital
Apr 10Is Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084) A Good Fit For Your Dividend Portfolio?
Mar 06Green Future Food Hydrocolloid Marine Science's(HKG:1084) Share Price Is Down 11% Over The Past Year.
Feb 08How Much Of Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084) Do Insiders Own?
Jan 18We Think Green Future Food Hydrocolloid Marine Science (HKG:1084) Is Taking Some Risk With Its Debt
Dec 28Could The Market Be Wrong About Green Future Food Hydrocolloid Marine Science Company Limited (HKG:1084) Given Its Attractive Financial Prospects?
Dec 10Should You Be Impressed By Green Future Food Hydrocolloid Marine Science's (HKG:1084) Returns on Capital?
Nov 23Financial Position Analysis
Short Term Liabilities: 1084's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥591.2M).
Long Term Liabilities: 1084's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥134.3M).
Debt to Equity History and Analysis
Debt Level: 1084's net debt to equity ratio (56.2%) is considered high.
Reducing Debt: 1084's debt to equity ratio has increased from 61.4% to 66% over the past 5 years.
Debt Coverage: 1084's debt is not well covered by operating cash flow (17.9%).
Interest Coverage: 1084's interest payments on its debt are not well covered by EBIT (2.2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/30 02:47 |
| End of Day Share Price | 2025/11/28 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Green Fresh Biotechnology Company Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.